Insider Selling: Arteris, Inc. (NASDAQ:AIP) CFO Sells 3,888 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) CFO Nicholas B. Hawkins sold 3,888 shares of the business’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total transaction of $27,682.56. Following the completion of the sale, the chief financial officer now directly owns 181,545 shares of the company’s stock, valued at $1,292,600.40. This represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Arteris Price Performance

Shares of NASDAQ AIP traded down $0.61 during trading hours on Friday, hitting $5.99. 225,185 shares of the stock were exchanged, compared to its average volume of 195,798. The company’s fifty day simple moving average is $8.70 and its two-hundred day simple moving average is $8.78. The company has a market cap of $245.28 million, a PE ratio of -6.88 and a beta of 1.21. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. Arteris, Inc. has a 1-year low of $5.76 and a 1-year high of $12.64.

Arteris (NASDAQ:AIP) last issued its earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). Arteris had a negative net margin of 58.27% and a negative return on equity of 828.71%. The business had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million. On average, sell-side analysts predict that Arteris, Inc. will post -0.73 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on AIP shares. Northland Securities boosted their price target on Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Wednesday, February 19th. Rosenblatt Securities reiterated a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Tuesday, February 18th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. PVG Asset Management Corp acquired a new stake in shares of Arteris in the 4th quarter valued at approximately $151,000. PharVision Advisers LLC bought a new position in Arteris in the 4th quarter valued at approximately $173,000. Squarepoint Ops LLC bought a new position in Arteris in the 4th quarter valued at approximately $160,000. Two Sigma Advisers LP boosted its position in Arteris by 82.9% in the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company’s stock valued at $240,000 after buying an additional 10,700 shares in the last quarter. Finally, Two Sigma Investments LP grew its stake in shares of Arteris by 166.0% during the fourth quarter. Two Sigma Investments LP now owns 60,533 shares of the company’s stock worth $617,000 after buying an additional 37,772 shares during the last quarter. Institutional investors own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.